Hepatitis A seroprevalence in Erzurum, Turkey.
CONCLUSIONS: In Erzurum, anti-HAV IgG prevalence is tremendously high, whereas prevalence of anti-HAV IgM is exceptionally low, especially in the paediatric age group. Therefore, HAV vaccine is provided free of charge in Turkey, including Erzurum, since 2012.
PMID: 32955233 [PubMed - in process]
Source: Annals of Agricultural and Environmental Medicine : AAEM - Category: Environmental Health Authors: Yilmaz A Tags: Ann Agric Environ Med Source Type: research
More News: Environmental Health | Hepatitis | Hepatitis A | Hepatitis Vaccine | International Medicine & Public Health | Laboratory Medicine | Microbiology | Middle East Health | Pediatrics | Study | Turkey Health | Vaccines | Women